Advertisement LDR wins Chinese approval for Mobi-C cervical artificial disc - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

LDR wins Chinese approval for Mobi-C cervical artificial disc

LDR, which develops implantable spine systems, has obtained approval in China to market its second generation Mobi-C cervical artificial disc.

This approval strengthens the company’s position in the growing Asian market through direct entities and confirms its position as a global spine solution company, said LDR.

LDR added that the controlled mobility of the Mobi-C’s mobile insert encourages restoration and respect of the instantaneous axis of rotation for a return to physiological mobility of the inter-vertebral disc and the cervical spine. This design also eliminates the need for invasive vertebral anchorage thus reducing the stresses on the bone-implant interface and facilitating multi-level implantations, according to the company.

Christophe Lavigne, CEO of LDR, said: “We are proud to introduce our cervical artificial disc into this strategic Asian market. The Mobi-C is a proven solution for cervical disc replacement with a simple, safe and reproducible surgical technique. The capacity of Mobi-C to be used for single or multilevel application is something I am sure that surgeons will appreciate and that positions us well against our competitors. LDR China, through our direct offices in Beijing and Shanghai, is prepared and excited to support the needs of our Chinese surgeon customers.”